Vasopressin and terlipressin in sepsis and systemic inflammatory response syndrome. Effects on microcirculation, oxygen transport, metabolism and organ function;Einsatz von vasopressin und terlipressin bei sepsis und systemischen entzündungsreaktionen. Auswirkungen auf mikrozirkulation, sauerstofftransport, metabolismus und organfunktion

Anaesthesist

Volumn 54, Issue 4, 2005, Pages 346-356

  Ertmer, C ^a   Sielenkamper A W ^a   Van Aken, H ^a   Bone, H G ^a   Westphal, M ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Microcirculation; Multiple organ failure; Oxygen delivery; Sepsis; Vasopressin

Indexed keywords

TERLIPRESSIN; VASOPRESSIN; DRUG DERIVATIVE; LYPRESSIN; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

FUNCTIONAL ASSESSMENT; HUMAN; HYPOTENSION; METABOLISM; MICROCIRCULATION; NONHUMAN; ORGAN; OXYGEN TRANSPORT; REVIEW; SEPSIS; SIDE EFFECT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; DRUG EFFECT; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY;

ANIMALS; HUMANS; LYSINE VASOPRESSIN; MICROCIRCULATION; OXYGEN CONSUMPTION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 18744407849     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-004-0796-8     Document Type: Review

References (73)

1. Andel D, Andel H, Hörauf K, Felfernig D, Millesi W, Zimpfer M (2001) The influence of deliberate hypotension on splanchnic perfusion balance with use of either isoflurane or esmolol and nitroglycerin. Anesth Analg 93:1116-1120
2. Aranow JS, Fink MP (1996) Determinants of intestinal barrier failure in critical illness. Br J Anaesth 77:71-81
3. Asfar P, Pierrot M, Veal N et al. (2003) Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 31:215-220
4. Auzinger GM, O'Callaghan PG, Harry RA, Wendon JA (2002) Terlipressin in the treatment of catecholamine resistant septic shock (abstract). Crit Care 6 [Suppl1]:P131
5. Backer D de, Creteur J, Preiser JC, Dubois MJ, Vincent JL (2002) Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 166:98-104
6. Bastien O, Piriou V, Aouifi A, Flamens C, Evans R, Lehot JJ (2000) Relative importance of flow versus pressure in splanchnic perfusion during cardiopulmonary bypass in rabbits. Anesthesiology 92:457-464
7. Bernadich C, Bandi JC, Bosch J (1998) Effects of F-180, a new selective vasoconstrictor peptide compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. Hepatology 27:351-356
8. Bersten AD, Holt AW (1995) Vasoactive drugs and the importance of renal perfusion pressure. New Horiz 3:650-661
9. Bracco D, Chioléro RL, Revelly JP (2001) Systemic and splanchnic hemodynamic effects of vasopressin administration in vasodilatory shock (abstract). Intensive Care Med 27 [Suppl 2]:S138
10. Browning L, Piekos K, Bander J, Guzman J (2003) Conventional versus high-dose titratable vasopressin infusions in the treatment of vasopressor dependent septic shock (abstract). Crit Care Med 31: A106
11. Bucher M, Hobbhahn J, Taeger K, Kurtz A (2002) Cytokin-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats. Am J Physiol Regul Integr Comp Physiol 282:R979-984
12. Chernow B, Rothl BL (1986) Pharmacological manipulation of the peripheral vasculature in shock: clinical and experimental approaches. Circ Shock 18:141-155
13. Cowley AW Jr, Cushman WC, Quillen EW Jr, Skelton MM, Langford HG (1981) Vasopressin elevation in essential hypertension and increased responsiveness to sodium intake. Hypertension 3:193-100
14. Day TA, Randle JC, Renaud LP (1985) Opposing α-and β-adrenergic mechanisms mediate dose-dependent actions of norepinephrine on supraoptic vasopressin neurons in vivo. Brain Res 358:171-179
15. Dubois MJ, Backer D de, Creteur J, Anane S, Vincent JL (2003) Effect of vasopressin on sublingual microcirculation in a patient with distributive shock. Intensive Care Med 29:1020-1023
16. Dünser MW, Mayr AJ, Ulmer H et al. (2001) The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardioto-my shock: a retrospective analysis. Anesth Analg 93:7-13
17. Dünser MW, Mayr AJ, Ulmer H et al. (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective randomized, controlled study. Circulation 107:2313-2319
18. Evora PR, Pearson PJ, Schaff HV(1993) Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery: V1-receptor-mediated production of nitric oxide. Chest 103:1241-1245
19. Giusti-Paiva A, Castro M de, Antunes-Rodrigues J, Carnio EC (2002) Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit Care Med 30:1306-1310
20. Guzman JA, Rosado AE, Kruse JA (2003) Vasopressin vs. norepinephrine in endotoxic shock: systemic, renal, and splanchnic hemodynamic and oxygen transport effects. J Appl Physiol 95:803-809
21. Haren FMP van, Rozendaal FW, Hoeven JG van der (2003) The effect of vasopressin on gastric perfusion in catecholamine-dependent septic shock patients. Chest 124:2256-2260
22. Holliger CH, Radzyner M, Knoblauch M (1983) Effects of glucagon, vasoactive intestinal peptide, and vasopressin on villous microcirculation and superior mesenteric artery blood flow of the rat. Gastroenterology 85:1036-1043
23. Holmes CL, Patel BM, Russell JA, Walley KR (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120:989-1002
24. Holmes CL, Landry DW, Granton JT (2003) Science review: vasopressin and the cardiovascular system part 1 - Receptor physiology. Crit Care 7:427-434
25. Ince C, Sinaasappel M (1999) Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 27:1369-1377
26. Jolley DH, Keulenaer BL de, Potter A, Stephens DP (2003) Terlipressin infusion in catecholamine-resistant shock. Anaesth Intensive Care 31:560-564
27. Kirton OC, Windsor J, Wedderburn R, Hudson-Civetta J, Shatz DV, Mataragas NR, Civetta JM (1998) Failure of splanchnic resuscitation in the acutely injured trauma patient correlates with multiple organ system failure and length of stay in the ICU. Chest 113:1064-1069
28. Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A (2003) High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31:2646-2650
29. Krejci V, Hiltebrand L, Hoevel M ten, Sigurdsson GH (2003) Hepato-splanchnic and pancreatic blood flow during administration of vasopressin in septic shock (abstract). Crit Care 7 [Suppl 2]:P48
30. +) channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J Clin Invest 89:2071-2074
31. Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 345:588-595
32. Landry DW, Levin HR, Gallant EM et al. (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122-1125
33. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA (1997) Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25:1279-1282
34. Levy B, Gawalkiewicz P, Vallet B, Briancon S, Nace L, Bollaert PE (2003) Gastric capnometry with air-automated tonometry predicts outcome in critically ill patients. Crit Care Med 31:474-480
35. Lowe RC, Grace ND (2001) Pharmacologic therapy for portal hypertension. Curr Gastroenterol Rep 3:24-29
36. Malay MB, Ashton RC, Landry DW, Townsend RN (1999) Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47:699-703
37. Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E (2003) The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 97:1756-1763
38. Martin CM, Yaghi A, Sibbald WJ, McCormack D, Paterson NAM (1993) Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. Am Rev Respir Dis 148:164-172
39. Mohring J, Glanzer K, Maciel JA Jr, Dusing R, Kramer HJ, Arbogast R, Koch-Weser J (1980) Greatly enhanced pressor response to antidiuretic hormone in patient with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol 2:367-376
40. Morelli A, Rocco M, Conti G et al. (2004) Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 30:597-604
41. Morrison HM, Doepfner P, Park GR (1991) Vasopressin in septic shock - A useful or dangerous agent? (correspondence). Intensive Care Med 17:242-243
42. 2 uptake during bacteremia in the dog. J Appl Physiol 63:1487-1489
43. O'Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine- resistant septic shock. Lancet 359:1209-1210
44. Papanek PE, Sladek CD, Raff H (1997) Corticosterone inhibition of osmotically stimulated vasopressin from hypothalamic-neurohypophysial explants. Am J Physiol 272:R158-162
45. Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96:576-582
46. Rackow EC, Astiz ME, Weil MH (1988) Cellular oxygen metabolism during sepsis and shock: the relationship of oxygen consumption to oxygen delivery. JAMA 259:1989-1993
47. Rivers E, Nguyen B, Havstad S et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377
48. Russell JA (1997) Gastric tonometry: does it work? Intensive Care Med 23:3-6
49. Russell JA (2003) Vasopressin in septic shock: clinical equipoise mandates a time for restraint. Crit Care Med 31:2707-2709
50. Russell JA, Ronco JJ, Lockhat D, Belzberg A, Kiess M, Dodek PM (1990) Oxygen delivery and consumption and ventricular preload are greater in survivors than in nonsurvivors of the adult respiratory distress syndrome. Am Rev Respir Dis 141:659-665
51. Russell JA, Cooper DJ, Walley KR et al. (2003) Vasopressin and Septic ShockTrial (VASST): baseline characteristics and organ dysfunction in vasopressor dependent patients with septic shock. Am J Respir Crit Care Med 167:A548
52. Scharte M, Meyer J, Aken H van, Bone HG (2001) Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 29:1756-1760
53. Schrier RW, Berl T, Anderson RJ (1979) Osmotic and nonosmotic control of vasopressin release. Am J Physiol 236:F321-332
54. Sharshar T, Calier R, Blanchard A et al. (2002) Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 30:497-500
55. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D (2003) Circulating vasopressin levels in septic shock. Crit Care Med 31:1752-1758
56. Silance PG, Simon C, Vincent JL (1994) The relation between cardiac index and oxygen extraction in acutely ill patients. Chest 105:1190-1197
57. Skowronski GA (1988) The pathophysiology of shock. Med J Aust 148:576-579, 582-583
58. Sun Q, Dimopoulos G, Nguyen DN et al. (2003) Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 168:481-486
59. Swaab DF, Nijveldt F, Pool CW (1975) Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus. J Endocrinol 67:461-462
60. Tarpey SB, Bennett T, Randall MD, Gardiner SM (1998) Differential effects of endotoxaemia on presser and vasoconstrictor actions of angiotensin II and argininevasopressin in conscious rats. Br J Pharmacol 123:1367-1374
61. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine (1999) Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 27:639-660
62. Taylor BS, Geller DA (2000) Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 13:413-424
63. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle W III (2001) Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29:487-493
64. 1) receptor in cultured rat mesangial cells. Am J Physiol 276:F433-441
65. Vincent JL (2002) Endocrine support in the critically ill. Crit Care Med 30:702-703
66. Vincent JL (2002) The available clinical tools - Oxygen-derived variables, lactate, and pHi. In: Vincent JL (ed) Tissue oxygenation in acute medicine. Update in intensive care medicine. Springer, Berlin Heidelberg New York, pp 193-203
67. Vincent JL (2003) The International Sepsis Forum's frontiers in sepsis: high cardiac output should be maintained in severe sepsis. Crit Care 7:276-278
68. +)-channel activities of cultured smooth muscle cells from porcine coronary artery. Am J Physiol 263:H491-496
69. Westphal M, Stubbe H, Sielenkämper AW, Ball C, Aken H van, Borgulya R, Bone HG (2003) Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep. Crit Care Med 31:1502-1508
70. Westphal M, Stubbe H, Sielenkämper AW, Borgulya R, Aken H van, Ball C, Bone HG (2003) Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 29:301-308
71. Westphal M, Ertmer C, Aken H van, Bone HG (2004) Terlipressin in patients with septic shock: friend or foe? Intensive Care Med 30:992
72. Westphal M, Freise H, Kehrel BE, Bone HG, Aken H van, Sielenkämper AW (2004) Arginine vasopressin compromises gut mucosal microcirculation in septic rats. Crit Care Med 32:194-200
73. Zerbe RL, Henry DP, Robertson GL (1983) Vasopressin response to orthostatic hypotension: etiologic and clinical implications. Am J Med 74:265-271